Released Jan 30, 2012, after the close
10-K filed Jan 30, 2012, 91 days after period end · 0001354488-12-000360
Q4 2011 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$824.43K$824.43K derivedno prior Q4 2010 on file−45.0% vs Q3 2011
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$2,140,439—
Operating Incomederived$1,030,137—
Operating Cash Flowderived$792,848—
Free Cash Flowderived$738,101—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
no prior Q4 2010 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR